Torrent Pharmaceuticals Ltd 2018 AR2
The report highlights Torrent Pharmaceuticals Limited's strategic acquisitions during the 2017-18 fiscal year, including the branded business of Unichem Laboratories in India and Nepal, and Bio-Pharm, Inc. in the US. The company consolidated its position as the 8th largest player in the Indian Pharmaceutical Market, registering a 9% growth in its domestic business. On the sustainability front, Torrent launched the REACH child-centric healthcare program, developed public parks, and installed a 1 MW solar rooftop plant at its Indrad facility to reduce carbon emissions.
Company: Torrent Pharmaceuticals Ltd
Sector: Health Care
Country: India
Year: 2018
Type: AR2
Pages: 212
Torrent Pharmaceuticals Ltd
Annual Report
The report highlights Torrent Pharmaceuticals Limited's strategic acquisitions during the 2017-18 fiscal year, including the branded business of Unichem Laboratories in India and Nepal, and Bio-Pharm, Inc. in the US. The company consolidated its position as the 8th largest player in the Indian Pharmaceutical Market, registering a 9% growth in its domestic business. On the sustainability front, Torrent launched the REACH child-centric healthcare program, developed public parks, and installed a 1 MW solar rooftop plant at its Indrad facility to reduce carbon emissions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Apr 1, 2017 - Mar 31, 2018
Fiscal Year
2018
Published
Aug 2, 2018
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees